There is currently no effective treatment method available for liver fibrosis. We therefore evaluated the use of Wharton's jelly stem cells (WJSCs; the major umbilical cord stem cell population) to treat chemically induced liver fibrosis via intraperitoneal injection of thioacetamide. WJSCs were transplanted into liverdamaged rats via the portal vein and the treatment was evaluated by assessing serum biochemistry and histopathology. Transplanted WJSCs were distributed in the fibrotic area and around blood vessels, and hepatic recovery was accelerated. Serum prothrombin time significantly recovered, and serum albumin also improved at 21 days posttransplantation; collagen accumulation also decreased at 14 days. Thus, human WJSCs promoted recovery after chronic liver damage. Using immunohistochemical analyses, we determined that transplanted WJSCs produce albumin, hepatocyte growth factor (HGF), and metalloproteinase (MMP) after transplantation to chemically injured liver, indicating that WJSC may help to decrease liver collagen and thus may be useful for treating liver fibrosis.
INTRODUCTION
33) and hepatocyte-like cells (3, 21, 25, 27, 30, 37, 39) . In addition, in vivo studies indicate that transplanted stem cells can differentiate into hepatocyte-like cells and ex-According to the World Health Organization (WHO) census, chronic liver diseases are a serious worldwide press specific markers such as albumin, tryptophan 2, 3-dioxygenase, and cytokeratin 18 (CK18) (5, 27, 35) . health problem (18) . Hepatitis B, hepatitis C, alcohol, and certain chemicals can result in liver fibrosis and cir-Transplantation of rat stem cells accelerates an animal's recovery following liver damage (2, 14, 15, 29, 38) . rhosis, and ultimately in liver failure. Currently, liver transplantation remains the only curative option for pa-Excess deposition of collagen is the main characteristic of liver fibrosis induced by chronic viral hepatitis, tients with liver failure (11).
The potential role for stem cell therapy in the treat-alcohol abuse, and drug toxicity. Metalloproteinase plays an important role in digesting collagen in fibrotic ment of liver diseases has lately become topical in medical research because of the self-renewal characteristics liver, and studies have revealed that increased expression of metalloproteinase can help to degrade collagen and differentiation potential of stem cells. Stem cells derived from bone marrow or umbilical cord blood have in the fibrotic liver (26, 28) . Further, other stem cells (e.g., mouse embryonic stem cells) can secrete metallo-the potential to become various kinds of cells (10,31- proteinase to degrade collagen, but this has not been The liver tissue was obtained from male C57BL/6 mice that had been exposed to a hepatotoxic reagent [thioacet-clearly established for Wharton's jelly stem cells.
Wharton's jelly from human umbilical cord is an im-amide (TAA) Sigma-Aldrich, St. Louis, MO, USA] at 350 mg/kg, intraperitoneally, 24 h prior to the coculture portant source of stem cells (22) . Wharton's jelly stem cells (WJSCs) are easily isolated and expanded ex vivo, experiment. On day 2 and day 4 during the coculture, total RNA from WJSC was extracted to examine the and under certain conditions they have the potential to differentiate into neuron-like and cartilage-like cells expression of liver-specific genes. Polymerase chain reaction (PCR) was performed using specific primers as (22) , and can be adipogenic, cardiogenic, chondrogenic, and osteogenic (36). To date, however, neither the he-follows: albumin-(F) 5′-TGCTTGAATGTGCTGAT GACAGGG-3′ and (R) 5′-AAGGCAAGTCAGCAGG patic differentiation potential of WJSC nor their potential in the treatment of liver fibrosis has been thoroughly CATCTCATC-3′; tryptophan 2,3-dioxygenase-(F) 5′-TGGTACTCTCCTCAATCTGCTG-3′ and (R) 5′-CTC described. Therefore, the purpose of this study was to evaluate the feasibility of WJSC therapy for managing TGGATTGACTGTGGAAGT-3′; α-fetoprotein-(F) 5′-ATACAGAGACTTCAGGAGC-3′ and (R) 5′-GTGAA thioacetamide-induced liver damage. A rat liver fibrosis model was established, and both liver biochemical func-GAGGGAAGACATAACTG-3′; hepatocyte growth factor (HGF)-(F) 5′-CAGATCATCCATTGCATTCG-3′ tion and the resulting histopathology were assessed to monitor the recovery from liver damage. and (R) 5′-ACTCCAGAGGCATTTCCATG-3′; metalloproteinase (MMP)-(F) 5′-TgAATgCCCTTgATgTC
MATERIALS AND METHODS
ATCCT-3′ and (R) 5′-ACACCTACACCAAgAACTT Cells and Cell Culture C-3′; CYP7A1-(F) 5′-GAGAAGGCAAACGGGTGA AC-3′ and (R) 5′-ATCGGGTCAATGCTTCTGTG-3′; The WJSCs used in this study were originally isonanog-(F) 5′-TGCCTCACACGGAGACTGTC-3′ and lated and expanded from a donated human umbilical (R) 5′-TGCTATTCTTCGGCCAGTTG-3′; oct4-(F) 5′cord with the donor's consent, according to a previously CTTGCTGCAGAAGTGGGTGGAGGAA-3′ and (R) 5′reported protocol (36). The WJSCs isolation was ap-CTGCAGTGTGGGTTTCGGGCA-3′; ckit-(F) 5′-AT proved by the Institutional Review Board of Buddhist GAGAGGCGCTCGCGGCGC-3′ and (R) 5′-AGCTTG Tzu Chi General Hospital. The cells obtained were cul-GCAGGATCTCTAAC-3′; glyceraldehyde 3 phosphate tured in Iscove's modified Dulbecco's medium (IMDM; dehydrogenase-(F) 5′-GGGCTGCTTTTAACTCTGG Invitrogen, Carlsbad, CA, USA) supplemented with T-3′ and (R) 5′-GCAGGTTTTTCTAGACGG-3′. PCR 10% fetal bovine serum (HyClone, Logan, UT, USA), was performed for 35 cycles, with each cycle consisting 10 ng/ml basic fibroblast growth factor (R&D, Minneapof denaturation for 30 s at 95°C, annealing for 30 s at olis, MN, USA), 2 mM L-glutamine, and 100 U/L peni-56-60°C (based on the primer set used), and elongation cillin-streptomycin (Invitrogen, Carlsbad, CA, USA) in for 60 s at 72°C, with a final 10-min incubation at 72°C. a 37°C incubator with 5% CO 2 . Cells with passage num-
The amplified cDNAs were analyzed by gel electrophober 10 to 20 were used in this study.
resis.
Surface Phenotype Characterization
Establishment of the Rat Liver Fibrosis Model WJSC surface markers were characterized by flow In this study, Wistar Kyoto (WKY) rats were obcytometry (FC500; Beckman Coulter, Brea, CA, USA) tained from LASCO CO., LTD (Taipei, Taiwain). All after being labeled with various antibodies, including procedures followed the ethical guidelines and were apthose against human CD105 (Santa Cruz Biotechnology, proved by the Institutional Animal Care and Use Com-Santa Cruz, CA, USA); CD13, CD14, CD29, CD34, mittee of Dong-Hwa University. CD44, CD45, HLA-DR, and IgG2a (Dako, Carpinteria, To establish the chronic liver fibrosis model in rat, CA, USA), and CD49b, CD49d, CD73, and CD90 (Bec-20 adult male WKY rats (320 ± 20 g) were used. Twelve ton Dickinson, Franklin Lakes, NJ, USA). Secondary out of 20 rats were intraperitoneally injected with 200 antibodies conjugated with fluorescein isothiocyanate mg/kg TAA (Sigma-Aldrich) once every 3 days for 60 were purchased from Chemicon (Temecula, CA, USA). days (i.e., 20 injections) as the fibrosis model group. In In Vitro Hepatic Differentiation the control group (8 out of 20 rats), normal saline was used in place of the TAA. At day 64 (i.e., 4 days after In vitro hepatic differentiation was tested by a modified coculture protocol (13) . With a trans-well mem-the last injection), these rats were sacrificed and cardiac blood samples were collected. These samples were ana-brane (pore size 0.4 µm; Becton Dickinson) separating the two cell populations, 3 × 10 4 WJSCs were cocultured lyzed with a biochemical analyzer (Integra 800; Roche, Holliston, MA, USA) to measure the liver function in-with 50 mg liver tissue in each well of a six-well plate. dex, which included glutamate oxaloacetate transami- molybdic acid-phosphotungstic acid (Sigma-Aldrich) for The cell transplantation protocol was modified from that reported previously (1,38). Thirty rats with TAA-15 min, and aniline blue (Sigma-Aldrich) for 5 min.
induced fibrotic livers were used for cell transplantations Cell Transplantation Experiment at day 64 (i.e., 4 days after the last TAA injection) as described in the establishment of the rat liver fibrosis WJSCs (2 × 10 7 ) that had been cultured in 75-cm 2 Tflasks as described above were detached by trypsiniza-model section. These rats were randomly divided into two groups for the transplantation experiment. Fifteen tion and collected by centrifugation. These cells were then resuspended in normal saline to a concentration of rats in the WJSC group were anesthetized with ether and injected with 1 × 10 6 WJSCs (in 0.5 ml of normal saline) 2thinsp;× 10 6 cells/ml. tochemistry kit (InnoGenex, San Ramon, CA, USA) was used to visualize the immune complexes. For immuno- fluorescence staining, sectioned paraffin-embedded liver of 10 different fields within each slide, which had been classified on a score of 0-3. A higher fibrosis score sig-samples were incubated overnight with anti-human mitochondria (1:50; Chemicon, Billerica, MA, USA). After nifies a more serious degree of liver fibrosis. By using this method, the liver fibrosis degree in each experimen-removing the primary antibody, rhodamine-conjugated anti-mouse secondary antibody (Chemicon, Billerica, tal group was determined. MA, USA) was added for 2 h, and the samples were Statistical Analysis then evaluated by fluorescence microscopy.
All data were shown as mean with SD. For the com-Quantification of Liver Fibrosis parison of different treatments in two groups, the data were analyzed by using the Student's t-test. Values of For quantification of liver fibrosis in each experimenp < 0.05 were considered significant. The Bonferroni tal group, Liver fibrosis was quantified using the method correction was used for the multiple comparisons. reported by Bruck et al. (7) . According to their method, the liver sections were stained with Masson's trichrome.
RESULTS The Masson's trichrome-stained liver tissue slices were
Characterization of WJSCs photographed and scored semiquantatively by three independent pathologists. The degrees of liver fibrosis of WJSC morphology and surface phenotype were evaluated by microscopy and flow cytometry, respectively. different experimental group were shown as the average The surface phenotypes of WJSCs isolated for this study TAA-damaged mouse liver tissue. RT-PCR showed that WJSCs cultured under the experimental conditions ex-were similar to that described previously for WJSCs (35) . The WJSCs obtained in this study did not express pressed liver-specific genes including CK18, albumin, tryptophan 2,3-dioxygenase (TO), α-fetoprotein (AFP), hematopoietic markers CD14, CD34, or CD45 but did express the mesenchymal stem cell markers CD29, and CYP7A1 (Fig. 2) . Further, the expression of stem cell genes, including nanog, oct4, and ckit, were de-CD44, CD49b, CD49d, CD73, CD90, and CD105, the myeloid marker CD13, and the major histocompatibility creased while WJSCs were cocultured with TAA-damaged liver. These results suggest that the WJSCs had the po-complex marker HLA-DR ( Fig. 1A-M ). In addition, these cells showed a fibroblast-like morphology (Fig. 1N) . tential to differentiate into hepatocyte-like cells in vitro.
In addition, the gene expression of HGF and MMP were The expression of hepatic-related WJSC genes, and thus the ability of these cells to undergo hepatic differ-increased while WJSCs differentiate into hepatocyte-like cells. entiation, was examined by coculturing WJSCs with 
Establishment of a Liver Fibrosis Model
WJSC transplantation ameliorated liver damage; recovery of tissue degeneration and vacuolation was evident in the and Evaluation of WJSC Cell Therapy WJSC group at day 21, whereas the sham group still showed serious inflammation and necrosis (Fig. 3C, D) . To confirm the liver fibrosis model, 12 of 20 rats were treated with TAA every 3 days for 60 days as the Masson's trichrome stain revealed severe accumulation of collagen in livers from the liver fibrosis rat group liver fibrosis rat group. The other rats (8 of 20) were treated with normal saline as a normal rat group. Rats (Fig. 4) . The quantification of the degree of liver fibrosis in the liver fibrosis rat group was significantly higher in both groups were sacrificed at day 64 to examine the liver function index and to score histopathology. In eval-than in the normal rat group (Table 3) . This suggested that TAA injection indeed induced liver fibrosis in rats. uation of WJSC cell therapy, 30 rats were subjected to TAA treatment as described for the liver fibrosis model. "Bridging," which results from accumulated collagen that connects two blood vessels, was found in most areas At day 64, rats were divided into two groups and either WJSCs (WJSC group) or saline (sham group) was intro-in the liver fibrosis group. This phenomenon was very similar to previous liver fibrosis reports (4, 6, 16, 20) and duced into the liver-damaged rats (n = 15 for each group) through the portal vein. Five rats from each was not found in the control group (Fig. 4A, B ). Using Masson's trichrome staining to assess collagen group were evaluated at days 7, 14, and 21 after transplantation, as described in Materials and Methods.
expression, there was no difference in collagen content at day 7 in the 10 rats analyzed from each group (Fig. In the liver fibrosis rat group, the GOT and GPT levels, compared to the normal rat group, were increased 4C, D, Table 1 ). Collagen degradation was found at day 14 in the WJSC group (Fig. 4E , F, Table 1 ). The WJSC (GOT from 110 ± 16 to 1034 ± 361 U/L, and GPT from 77 ± 10 to 185 ± 50 U/L), indicating liver damage (Ta-group rarely showed collagen accumulation at day 21 (Fig. 4G, Table 1 ), whereas the sham group still showed ble 1). Decreased albumin (from 4.11 ± 0.43 to 3.43 ± 0.08 g/dl) and significantly increased prothrombin time substantial collagen accumulation ( Fig. 4H , Table 1 ) at 21 days after transplantation. (from 9.4 ± 0.11 to 11.5 ± 1.0 s) were also found in the blood. The biochemical results in the TAA-induced liver
Monitoring Transplanted Cells fibrosis experiments were consistent with previous re-To follow the transplanted human cells in this study, ports (1, 16, 24, 38) , suggesting significantly reduced liver antibodies specific for human albumin, human mitofunction in these animals. In the WJSC group and the chondria, metalloproteinase, and human HGF were used sham group, biochemical liver function indices were to stain sectioned liver samples. The human albuminalso examined ( Table 2) . GOT and GPT levels declined positive cells were detected in the WJSC group up to 21 to near-normal values in both the WJSC and sham days after transplantation (Fig. 5A, B ) but in the sham groups at day 7 after transplantation. GOT and GPT levgroup the albumin-positive cells were not detected (Fig. els did not differ significantly between groups. The ob-5C, D). This result suggested that the transplanted served low GOT and GPT levels may be attributable to WJSCs differentiated into albumin-secreting hepatocytethe short half-lives of GOT and GPT (i.e., 17 and 47 h, like cells in the damaged livers of the rats from the respectively) (17) .
WJSC group. Immunohistochemical staining for metal-Although the GOT and GPT levels did not differ beloproteinase revealed many metalloproteinase-positive tween groups, prothrombin time indicated significant cells in the peri-venule and bile duct areas in the WJSC differences between the two groups at 21 days and the group (Fig. 6A ). However, metalloproteinase-positive albumin was approaching normal levels in the WJSC and human mitochondria-positive cells were not obgroup at 21 days. Prothrombin time was significantly served in the sham group (Fig. 6B) . The metalloproteidifferent between the WJSC group and the sham group nase-positive cells in the WJSC group were also cos-21 days after transplantation (9.5 ± 0.1 vs. 9.9 ± 0.2, tained with human mitochondria (Fig. 6C ) but were not p < 0.01). At 21 days posttransplantation, serum albuobserved in the sham group. This indicated that these min in the WJSC group had recovered to a greater extent metalloproteinase-positive cells were transplanted WJSCs. than in the sham group (3.84 ± 0.22 vs. 3.52 ± 0.14).
Further, the human HGF-positive cells were observed These changes suggest that liver function had recovered and along the collagen fiber in the damaged liver of the after 21 days of WJSC therapy (Table 2) .
WJSC group (Fig. 7A ) but were not observed in the Hematoxylin and eosin staining of normal rat liver sham group. This indicated that the transplanted WJSCs tissue sections indicated that there was no damage, as could express human HGF in damaged liver. expected (Fig. 3A) . In comparison, tissue vacuolation, DISCUSSION necrosis, and the degeneration of cell nuclei were observed in liver sections from TAA-induced liver fibrosis
We have established a model system for studying liver damage following periodic injections of TAA for rats ( Fig. 3B ). Histopathologic data also suggested that 60 days. In this study, WJSCs had the potential to differ-to the degradation of collagen fibers in TAA-induced liver fibrosis. Further investigation is required to eluci-entiate into hepatocyte-like cells when cocultured with chemically damaged mouse liver in vitro. The biochemi-date the precise mechanism of collagen degradation that occurs after WJSC transplantation. cal liver function index and histopathological analysis from in vivo experiments revealed that the human WJSCs
In conclusion, our results demonstrate that WJSC could different into hepatocyte-like cells in vitro. The promoted the recovery of TAA-induced hepatic damage and thus may have potential cell therapy applications.
WJSC also could express MMP and HGF in vitro. In addition, in an in vivo study WJSC differentiated into There are several explanations for the amelioration of TAA-induced liver damage facilitated by WJSCs. First, hepatocyte-like cells. Besides, WJSC could express HGF and metalloproteinase, an attribute that also was ob-immunostaining of WJSCs incorporated into the TAAinduced fibrotic liver indicated that WJSCs could differ-served in the surrounding bile duct, in vivo. The expression of HGF and metalloproteinase in undifferentiated entiate into albumin-producing hepatocyte-like cells (Fig. 5A, B ). The in vitro study showed that WJSCs WJSC as well as the WJSC-mediated differentiation of cells into hepatocyte-like cells facilitated regeneration of expressed liver-specific genes when cocultured with chemically damaged liver tissue (Fig. 2) . These hepato-damaged liver in TAA-induced liver fibrosis. WJSC, the major stem cell population of the umbilical cord, are cyte-like cells that differentiated from WJSCs may play an important role in liver function recovery. Moreover, thus a promising source of cells for the treatment of liver fibrosis. in the animal study, the WJSC-derived hepatocyte-like cells were likely responsible for facilitating the recovery (8, 9, 19, 23, 40) . The WJSCs used in this study could express HGF mRNA (Fig. 2) and secrete HGF in fibrotic REFERENCES liver (Fig. 7) . This led us to speculate that the WJSCs could secrete HGF and accelerate liver recovery. Third,
